Please use this identifier to cite or link to this item: https://hdl.handle.net/10923/11623
Full metadata record
DC FieldValueLanguage
dc.contributor.authorDE VELASCO, GUILLERMO-
dc.contributor.authorGRAY, KATHRYN P.-
dc.contributor.authorHAMIEH, LANA-
dc.contributor.authorURUN, YUKSEL-
dc.contributor.authorCAROL, HALLIE A.-
dc.contributor.authorAndré Poisl Fay-
dc.contributor.authorSIGNORETTI, SABINA-
dc.contributor.authorKWIATKOWSKI, DAVID J.-
dc.contributor.authorMCDERMOTT, DAVID F.-
dc.contributor.authorFREEDMAN, MATTHEW-
dc.contributor.authorPOMERANTZ, MARK M.-
dc.contributor.authorCHOUEIRI, TONI K.-
dc.date.accessioned2018-05-30T13:34:51Z-
dc.date.available2018-05-30T13:34:51Z-
dc.date.issued2016-
dc.identifier.issn2405-4569-
dc.identifier.urihttp://hdl.handle.net/10923/11623-
dc.language.isoen-
dc.relation.ispartofEuropean Urology Focus-
dc.rightsopenAccess-
dc.titlePharmacogenomic Markers of Targeted Therapy Toxicity in Patients with Metastatic Renal Cell Carcinoma-
dc.typeArticle-
dc.date.updated2018-05-30T13:34:50Z-
dc.identifier.doiDOI:10.1016/j.euf.2016.03.017-
dc.jtitleEuropean Urology Focus-
dc.volume2-
dc.issue6-
dc.spage633-
dc.epage639-
Appears in Collections:Artigo de Periódico



All Items in PUCRS Repository are protected by copyright, with all rights reserved, and are licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. Read more.